Erratum to: Diabetes Ther DOI 10.1007/s13300-017-0247-6
In the original publication, the data have been incorrectly updated within the results, discussion and Table 2. The correct data are given here.
The result in Table 2, presenting Hypoglycemic events at Week 12 currently reads: 2 (1.7).
This result should read: 2 (3.2).
The result in Table 2 presenting Hypoglycemic events at Week 36 reads: 3 (2.5).
This result should read: 3 (4.8).
The result in Table 2 presenting the Hypoglycemic events p value currently reads: 1.000.
This p value should read: 0.500.
The statement within the results section reads:
‘There was no significant difference in the incidence of hypoglycemia before and after treatment (1.7% vs. 2.5% χ
2 = 0.21; p = 1.000) (Table 2).’
This statement should read:
‘There was no significant difference in the incidence of hypoglycemia before and after treatment (3.2% vs. 4.8%
χ
2 = 0.50;
p = 0.500) (Table
2).’
Table 2
Changes in clinical parameters after 24 weeks’ basal-plus treatment
HbA1c (%) | 8.06 (0.71) | 7.17 (0.54) | 0.89 (0.56)* | <0.001 |
FBG (mmol/L) | 6.23 (0.15) | 6.20 (0.16) | 0.03 (0.14) | 0.118 |
PBG (mmol/L) | 13.17 (1.72) | 10.14 (2.20) | 3.03 (1.53)* | <0.001 |
Basal insulin dosage (IU/kg/day) | 0.36 (0.06) | 0.35 (0.05) | 0.01 (0.02) | 0.073 |
Prandial insulin dosage (IU/kg/day) | 0 (0) | 0.14 (0.04) | 0.14 (0.04)* | <0.001 |
Total insulin dosage (IU/kg/day) | 0.36 (0.06) | 0.50 (0.08) | 0.14 (0.03)* | <0.001 |
Weight (kg) | 73.19 (6.82) | 73.28 (6.90) | 0.08 (0.76) | 0.379 |
Number of OADs used | 2.71 (0.46) | 2.12 (0.42) | 0.60 (0.61)* | <0.001 |
OADs, n (%) |
α-glycosidase inhibitor | 63 (100) | 22 (34.9) | | |
Metformin | 18 (28.6) | 63 (100) | | |
Insulin secretagogue | 59 (93.7) | 10 (15.9) | | |
Hypoglycemic events, n (%) | 2 (3.2) | 3 (4.8) | | 0.500 |
Other adverse events, n (%) | 0 (0) | 0 (0) | | |
The statement the discussion section reads: ‘In particular, the 40% of subjects in the present study who.’
This statement should read: ‘In particular, the 36.7% of subjects in the present study who.’
Open Access
This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (
http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (
https://creativecommons.org/licenses/by/4.0), which permits use, duplication, adaptation, distribution, and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.